← Back to Search

Other

Subcision for Acne Scars

N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have bilateral rolling acne scars on each side of their face
Age 18 to 65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 36 weeks
Awards & highlights

Study Summary

This trial is testing whether multiple subcisions over several visits can improve the appearance of rolling acne scars better than no treatment.

Who is the study for?
This trial is for adults aged 18 to 65 with rolling acne scars on both sides of their face, who are in good health and have no active acne. Participants must understand the study and give informed consent. It's not for those under 18, pregnant or breastfeeding women, recent Accutane users, individuals prone to severe scarring or with blood diseases like HIV or Hepatitis, or a history of Herpes.Check my eligibility
What is being tested?
The trial is testing if multiple subcision treatments can improve the look of rolling acne scars compared to no treatment at all. This pilot study will assess how feasible this procedure is over several visits.See study design
What are the potential side effects?
While specific side effects aren't listed here, subcision procedures may typically cause temporary bruising, swelling, pain at the treated area and risk of infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have deep acne scars on both sides of my face.
Select...
I am between 18 and 65 years old.
Select...
I do not have active acne.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in acne scarring compared to baseline after treatments

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multiple SubcisionExperimental Treatment1 Intervention
Subjects will receive multiple subcision treatments to their randomized side of the face 5 times total spaced 4 weeks apart.
Group II: ControlActive Control1 Intervention
Subjects will receive no intervention control on the other side of the face.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,226 Total Patients Enrolled
3 Trials studying Acne Scars
44 Patients Enrolled for Acne Scars
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,575 Total Patients Enrolled
3 Trials studying Acne Scars
44 Patients Enrolled for Acne Scars

Media Library

Multiple Subcision (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02216864 — N/A
Acne Scars Research Study Groups: Control, Multiple Subcision
Acne Scars Clinical Trial 2023: Multiple Subcision Highlights & Side Effects. Trial Name: NCT02216864 — N/A
Multiple Subcision (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02216864 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Illinois
Minnesota
How old are they?
18 - 65
What site did they apply to?
Northwestern University Feinberg School of Medicine, Department of Dermatology
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

What questions have other patients asked about this trial?

How many visits will be required?
PatientReceived 1 prior treatment
~0 spots leftby Dec 2024